Oxadiazoles are a class of heterocyclic aromatic compounds with the molecular formula C2H2N2O, which have special biological activities and thermodynamic properties. Five-membered heterocyclic moieties composed of three or two heteroatoms are of great interest to researchers because these compounds show significant therapeutic potential. These heterocycles can serve as a building block for the development of novel molecular structures.
Evaluate Pharma recently issued an article listing "the most valuable potential drugs currently under development", and Aficamten is one of them. Aficamten is a novel cardiac myosin inhibitor for the treatment of hypertrophic cardiomyopathy, which achieves its therapeutic effect by reducing the hypercontractility of obstructive HCM and improving diastolic function.
Search 
+86 21 5895 0110 
